|1.||Ducic, Yadranko: 3 articles (02/2010 - 03/2002)|
|2.||Bambakidis, Nicholas C: 2 articles (07/2013 - 05/2010)|
|3.||Megerian, Cliff A: 2 articles (07/2013 - 05/2010)|
|4.||Chen, Douglas A: 2 articles (06/2007 - 05/2002)|
|5.||Joist, A: 2 articles (08/2004 - 06/2000)|
|6.||Frebel, T: 2 articles (08/2004 - 06/2000)|
|7.||Joosten, U: 2 articles (08/2004 - 06/2000)|
|8.||Kveton, J F: 2 articles (05/2001 - 10/2000)|
|9.||Woodworth, Graeme F: 1 article (04/2015)|
|10.||Jackson, Christopher: 1 article (04/2015)|
08/01/2004 - "A study was performed to investigate the effectiveness of hydroxyapatite cement (HAC) as a new carrier system in the treatment of chronic, posttraumatic osteomyelitis. "
06/01/1992 - "This hydroxyapatite cement drug-delivery system can be applied in the treatment of osteomyelitis and infected compound fractures."
10/01/1991 - "This hydroxyapatite cement drug delivery system can be applied in the treatment of osteomyelitis and infected compound fractures."
02/01/1999 - "Efficacy of gentamycin-impregnated resorbable hydroxyapatite cement in treating osteomyelitis in a rat model."
09/01/2005 - "The present study aimed to investigate hydroxyapatite cement (HAC) as a carrier for vancomycin in the treatment of chronic osteomyelitis due to Staphylococcus aureus strains with various mechanisms of resistance. "
|2.||Compression Fractures (Compression Fracture)
11/01/2002 - "This comparative ex vivo biomechanical study was designed to determine the strength and stiffness of osteoporotic vertebral bodies (VBs) subjected to compression fractures and stabilized with bipedicular injections of Cranioplastic altered in a manner consistent with the practice of vertebroplasty or BoneSource cement. "
10/01/2001 - "In this study the authors compare the stabilizing effects of the HA product, BoneSource, with PMMA in an experimental compression fracture of L-1. "
07/15/2001 - "To determine the strength and stiffness of osteoporotic vertebral bodies subjected to compression fractures and stabilized via bipedicular injections of the following: 1) Simplex P (Stryker-Howmedica-Osteonics, Rutherford, NJ), 2) Simplex P formulated consistent with the practice of vertebroplasty (F2), or 3) BoneSource (Stryker-Howmedica-Osteonics). "
|3.||Wounds and Injuries (Trauma)
12/01/2002 - "This prospective, randomized study was performed to determine whether a new, in situ setting hydroxyapatite cement is as safe or effective as autologous cancellous bone graft for the treatment of metaphyseal bone voids secondary to trauma. "
11/01/2006 - "Frontobasal trauma (26 patients [68%] in the BoneSource group and 9 patients [56%] in the fat obliteration group) was the most common history of mucocele formation in both groups. "
05/01/2002 - "Hydroxyapatite cement cranioplasty (HAC) after translabyrinthine resection of acoustic neuroma is a promising new technique for wound reconstruction. "
01/01/2002 - "To evaluate the efficacy hydroxyapatite cement as an alternative to autologous fat in the obliteration of the frontal sinus after trauma or chronic suppuration. "
03/01/2002 - "Twenty consecutive calvarial defects (10 to 156 cm(2)) that resulted from surgical removal of neoplasms or were secondary to trauma were reviewed retrospectively after reconstruction with titanium mesh and hydroxyapatite cement. "
01/01/2011 - "Although hydroxyapatite cement can yield excellent aesthetic results, its use in secondary reconstruction has yielded unacceptably high infection rates leading to discontinuation of its use in this patient population."
02/01/2007 - "The use of hydroxyapatite cement within the frontal sinus has been questioned due to recent data regarding late infection and exposure. "
01/01/2005 - "It has been the authors' experience that hydroxyapatite cement is both biocompatible and resistant to infection when used in sites not contiguous with sinus mucosa; and that it is a good alternative to autogenous bone in pediatric craniofacial reconstruction."
01/01/2004 - "In four of eight patients who had obliteration using hydroxyapatite cement, there was infection of the obliteration site, requiring revision. "
02/01/2010 - "No flap failures, 1 transient CSF leak, 3 hardware exposures distant from the temporalis recipient site, and 3 hydroxyapatite cement infections or foreign body reaction were observed. "
|2.||Polymethyl Methacrylate (Sol)
|5.||Prostheses and Implants (Prosthesis)